Right now, most psychedelics sit in Schedule I — the US government's strictest drug category, reserved for substances it considers to have no accepted medical use and high abuse potential. Despite growing research interest, there's a 75% chance this doesn't change in the next 12 months. Approving a single drug doesn't automatically change the rules for the whole category.
No legislative movement today and diversion cases keep mounting. FDA approval of a single drug is not descheduling. Control structures remain.